References
- BasakSBeharMHoffmannALessons from mathematically modeling the NF-κB pathwayImmunol Rev2012246122123822435558
- OeckinghausAGhoshSThe NF-kappaB family of transcription factors and its regulationCold Spring Harb Perspect Biol200914a00003420066092
- KarinMYamamotoYWangQMThe IKK NF-kappa B system: a treasure trove for drug developmentNat Rev Drug Discov200431172614708018
- ChristianFSmithECarmodyRThe regulation of NF-κB subunits by phosphorylationCells20165112
- RazaniBZarnegarBYtterbergAJNegative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylationSci Signal20103123ra4120501937
- GrayCMRemouchampsCMccorkellKANoncanonical NF-κB signaling is limited by classical NF-κB activitySci Signal20147311ra1324497610
- OeckinghausAHaydenMSGhoshSCrosstalk in NF-κB signaling pathwaysNat Immunol201112869570821772278
- ShihVF-STsuiRCaldwellAHoffmannAA single NFκB system for both canonical and non-canonical signalingCell Res20112118610221102550
- ChenL-FGreeneWCShaping the nuclear action of NF-κBNat Rev Mol Cell Biol20045539240115122352
- CollinsPMitxitorenaICarmodyRThe ubiquitination of NF-κB subunits in the control of transcriptionCells20165223
- LiangPZhangHWangGKPNB1, XPO7 and IPO8 mediate the translocation of NF-kappaB/p65 into the nucleusTraffic2013141132114323906023
- BaylissRCorbettAHStewartMThe molecular mechanism of transport of macromolecules through nuclear pore complexesTraffic20001644845611208130
- KorwekZTudelskaKNałęcz-JaweckiPImportins promote high-frequency NF-κB oscillations increasing information channel capacityBiol Direct20161116127835978
- PhelpsCBSengchanthalangsyLLMalekSGhoshGMechanism of kappa B DNA binding by Rel/NF-kappa B dimersJ Biol Chem2000275243922439910825175
- SchmitzMLBaeuerlePAThe p65 subunit is responsible for the strong transcription activating potential of NF-kappa BEmbo J19911012380538171935902
- van EssenDEngistBNatoliGSaccaniSTwo modes of transcriptional activation at native promoters by NF-kappaB p65PLoS Biol200973e7319338389
- KoyanagiMHijikataMWatashiKMasuiOShimotohnoKCentrosomal P4.1-associated protein is a new member of transcriptional coactivators for nuclear factor-kappaBJ Biol Chem200528013124301243715687488
- UranishiHTetsukaTYamashitaMInvolvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivatorJ Biol Chem200127616133951340111278855
- HuangTTKudoNYoshidaMMiyamotoSA nuclear export signal in the N-terminal regulatory domain of Ikappa Balpha controls cytoplasmic localization of inactive NF-kappa B/Ikappa Balpha complexesProc Natl Acad Sci20009731014101910655476
- HuxfordTHuangDBMalekSGhoshGThe crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivationCell19989567597709865694
- JacobsMDHarrisonSCStructure of an IkappaBalpha/NF-kappaB complexCell1998957497589865693
- Arenzana-SeisdedosFThompsonJRodriguezMSBachelerieFThomasDHayRTInducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa BMol Cell Biol1995155268926967739549
- BaldwinASRegulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancerImmunol Rev2012246132734522435564
- YdePMengelBJensenMHKrishnaSTrusinaAModeling the NF-κB mediated inflammatory response predicts cytokine waves in tissueBMC Syst Biol20115111521771307
- FagerlundRKinnunenLKohlerMJulkunenIMelenKNF-{kappa} B is transported into the nucleus by importin {alpha}3 and importin {alpha}4J Biol Chem2005280159421595115677444
- KöhlerMSpeckCChristiansenMEvidence for distinct substrate specificities of importin alpha family members in nuclear protein importMol Cell Biol199919117782779110523667
- SteinBCogswellPCBaldwinASFunctional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interactionMol Cell Biol1993137396439748321203
- HuangBYangX-DLambAChenL-FPosttranslational modifications of NF-κB: another layer of regulation for NF-κB signaling pathwayCell Signal20102291282129020363318
- BarnesPJKinases as novel therapeutic targets in asthma and chronic obstructive pulmonary diseasePharmacol Rev201668378881527363440
- ZhongHSuyangHErdjument-BromageHTempstPGhoshSThe transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanismCell19978934134249150141
- ReberLVermeulenLHaegemanGFrossardNSer276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammationPLoS One200942e439319197368
- RyoASuizuFYoshidaYRegulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelAMol Cell20031261413142614690596
- BussHDörrieASchmitzMLPhosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activityJ Biol Chem200427948495714957415465828
- MattioliIGengHSebaldAInducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilonJ Biol Chem2006281106175618316407239
- MsakiASánchezAMKohLFThe role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migrationMol Biol Cell201122173032304021737676
- KarinMBen-NeriahYPhosphorylation meets ubiquitination: the control of NF-κB activityAnnu Rev Immunol200018162166310837071
- SakuraiHChibaHMiyoshiHSugitaTToriumiWIkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domainJ Biol Chem199927443303533035610521409
- ViatourPMervilleM-PBoursVChariotAPhosphorylation of NF-κB and IκB proteins: implications in cancer and inflammationTrends Biochem Sci2005301435215653325
- BussHHandschickKJurrmannNCyclin-dependent kinase 6 phosphorylates NF-κB P65 at serine 536 and contributes to the regulation of inflammatory gene expressionPLoS One2012712e5184723300567
- HandschickKBeuerleinKJuridaLCyclin-dependent kinase 6 is a chromatin-bound cofactor for NF-κB-dependent gene expressionMol Cell201453219320824389100
- ShanmugasundaramKNayakBShimEHLiviCBBlockKSudarshanSThe oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-κB signalingJ Biol Chem201428935246912469925028521
- DekkerFJvan den BoschTMartinNISmall molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseasesDrug Discov Today201419565466024269836
- CalaoMBurnyAQuivyVDekoninckAvan LintCA pervasive role of histone acetyltransferases and deacetylases in an NF-κB-signaling codeTrends Biochem Sci200833733934918585916
- ChenL-FMuYGreeneWCAcetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaBEmbo J200221236539654812456660
- KiernanRBrèsVNgRWMPost-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65J Biol Chem200327842758276612419806
- YeungFHobergJERamseyCSModulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylaseEmbo J200423122369238015152190
- BuerkiCRothgiesserKMValovkaTFunctional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65Nucleic Acids Res20083651665168018263619
- HuangBYangX-DZhouM-MOzatoKChenL-FBrd4 coactivates transcriptional activation of NF- B via specific binding to acetylated RelAMol Cell Biol20092951375138719103749
- KimJ-WJangS-MKimC-HAnJ-HKangE-JChoiK-HNew molecular bridge between RelA/p65 and NF-κB target genes via histone acetyltransferase TIP60 cofactorJ Biol Chem2012287107780779122249179
- LuTStarkGRNF-κB: regulation by methylationCancer Res201575183692369526337909
- LuTStarkGRUsing sequential immunoprecipitation and mass spectrometry to identify methylation of NF-kappaBMethods Mol Biol2015128038339325736762
- CkEBaltimoreDRegulation of NF-kappaB activity through lysine monomethylation of p65Proc Natl Acad Sci U S A2009106189721897719864627
- WeiHWangBMiyagiMPRMT5 dimethylates R30 of the p65 subunit to activate NF- BProc Natl Acad Sci U S A201311033135161352123904475
- YangX-DHuangBLiMLambAKelleherNLChenL-FNegative regulation of NF-κB action by Set9-mediated lysine methylation of the RelA subunitEmbo J20092881055106619262565
- LuTJacksonMWWangBRegulation of NF- B by NSD1/FBXL11-dependent reversible lysine methylation of p65Proc Natl Acad Sci U S A20101071465120080798
- QuivyVvan LintCRegulation at multiple levels of NF-κB-mediated transactivation by protein acetylationBiochem Pharmacol20046861221122915313420
- BhattDGhoshSRegulation of the NF-κB-mediated transcription of inflammatory genesFront Immunol201457124611065
- ChenL-FWilliamsSAMuYNF- B RelA phosphorylation regulates RelA acetylationMol Cell Biol200525187966797516135789
- GaoJXuDCorrelation between posttranslational modification and intrinsic disorder in proteinPac Symp Biocomput20129410322174266
- SrinivasanMDunkerAKProline rich motifs as drug targets in immune mediated disordersInt J Pept201220127 Article ID 63476914
- TakadaYSinghSAggarwalBBIdentification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosisJ Biol Chem200427915150961510414711835
- MacaraIGTransport into and out of the nucleusMicrobiol Mol Biol Rev200165457059411729264
- ChewJBiswasSShreeramSWIP1 phosphatase is a negative regulator of NF-κB signallingNat Cell Biol200911565966619377466
- YangJFanGHWadzinskiBESakuraiHRichmondAProtein phosphatase 2A interacts with and directly dephosphorylates RelAJ Biol Chem200127651478284783311591705
- YehPYYehKHChuangSESongYCChengALSuppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylationJ Biol Chem200427925261432614815073167
- LuTYangMHuangDBRole of lysine methylation of NF-κB in differential gene regulationProc Natl Acad Sci U S A201311033135101351523904479
- GengHWittwerTDittrich-BreiholzOKrachtMSchmitzMLPhosphorylation of NF-κB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal eliminationEMBO Rep200910438138619270718
- BussHDörrieASchmitzMLHoffmannEReschKKrachtMConstitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcriptionJ Biol Chem200427953556335564315489227
- CalzadoMBacherSSchmitzMLNF-kappaB inhibitors for the treatment of inflammatory diseases and cancerCurr Med Chem200714336737617305539
- GaspariniCFeldmannMNF-kappaB as a target for modulating inflammatory responsesCurr Pharm Des201218355735574522726116
- GuptaSCSundaramCReuterSAggarwalBBInhibiting NF-kappaB activation by small molecules as a therapeutic strategyBiochim Biophys Acta2010179977578720493977
- LiuTZhangLJooDSunSCNF-κB signaling in inflammationSignal Transduct Target Ther201721702329158945
- UweSAnti-inflammatory interventions of NF-kappaB signaling: potential applications and risksBiochem Pharmacol20087581567157918070616
- UehlingDEHarrisPARecent progress on MAP kinase pathway inhibitorsBioorg Med Chem Lett201525194047405626298497
- SahaRNJanaMPahanKMAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65J Immunol2007179107101710917982102
- AlamJBlackburnKPatrickDNeflamapimod: clinical phase 2b-ready oral small molecule inhibitor of p38alpha to reverse synaptic dysfunction in early Alzheimer’s diseaseJ Prev Alzheimers Dis2017427327829181493
- BühlerSLauferSAp38 MAPK inhibitors: a patent review (2012 – 2013Expert Opin Ther Pat201424553555424611721
- FujiharaSMCleavelandJSGrosmaireLSA D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory diseaseJ Immunol200016521004101210878377
- LinYZYaoSYVeachRATorgersonTRHawigerJInhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequenceJ Biol Chem19952702414255142587782278
- WangYFXuXFanXA cell-penetrating peptide suppresses inflammation by inhibiting NF-κB signalingMol Ther201119101849185721556052
- NadlerSGTritschlerDHaffarOKBlakeJBruceAGCleavelandJSDifferential expression and sequence-specific interaction of karyopherin alpha with nuclear localization sequencesJ Biol Chem19972727431043159020149
- van der WattPJChiAStelmaTTargeting the nuclear import receptor Kpn 1 as an anticancer therapeuticMol Cancer Ther201615456057326832790
- KashyapTArguetaCAboukameelASelinexor, a selective inhibitor of nuclear export (SINE) compound, acts through NF-kappaB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell deathOncotarget2016748788837889527713151
- StelmaTLeanerVDKPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cellsOncotarget2017820328333284728427184
- OlivaBFernandez-FuentesNKnowledge-based modeling of peptides at protein interfaces: PiPreDBioinformatics20153191405141025540186
- SrinivasanMInterface peptide mimetics: rationale and applications as therapeutic agentsMed Chem (Los Angeles)201663189194
- RaoNASMccalmanMTMoulosPCoactivation of GR and NFKB alters the repertoire of their binding sites and target genesGenome Res20112191404141621750107
- YamamotoKRSteroid receptor regulated transcription of specific genes and gene networksAnnu Rev Genet19851912092523909942
- RiccardiCGILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoidsAnn Ig201022535920701225
- AyroldiERiccardiCGlucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid actionFaseb J200923113649365819567371
- SrinivasanMBayonBChopraNLahiriDKNovel nuclear factor-kappaB targeting peptide suppresses β-amyloid induced inflammatory and apoptotic responses in neuronal cellsPLoS One20161110e016031427764084
- CubellisMVCaillezFBlundellTLLovellSCProperties of polyproline II, a secondary structure element implicated in protein-protein interactionsProteins200558488089215657931
- SrinivasanMBlackburnCLahiriDKFunctional characterization of a competitive peptide antagonist of p65 in human macrophage-like cells suggests therapeutic potential for chronic inflammationDrug Des Devel Ther2014824092421
- SrinivasanMJanardhanamSNovel p65 binding glucocorticoid-induced leucine zipper peptide suppresses experimental autoimmune encephalomyelitisJ Biol Chem201128652447994481021965677
- O’SheaJMPerkinsNDRegulation of the RelA (p65) transactivation domainBiochem Soc Trans200836460360818631125
- GerritsenMEWilliamsAJNeishASMooreSShiYCollinsTCREB-binding protein/p300 are transcriptional coactivators of p65Proc Natl Acad Sci U S A1997947292729329096323
- LeeSKKimJHLeeYCCheongJLeeJWSilencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factorJ Biol Chem200027517124701247410777532
- DennlerSDijkeTSmad proteins in TGF-beta signalingSchwabMEncyclopedia of CancerBerlinSpringer2011
- Hirata-TsuchiyaSFukushimaHKatagiriTInhibition of BMP2-induced bone formation by the p65 subunit of NF-κB via an interaction with Smad4Mol Endocrinol20142891460147025029242
- UrataMKokabuSMatsubaraTA peptide that blocks the interaction of NF-κB p65 subunit with Smad4 enhances BMP2-induced osteogenesisJ Cell Physiol201823397356736629663368
- HeckerMWagnerAHTranscription factor decoy technology: a therapeutic updateBiochem Pharmacol2017144293428642036
- MorishitaRSugimotoTAokiMIn vivo transfection of cis element “decoy” against nuclear factor-kappaB binding site prevents myocardial infarctionNat Med1997388948999256281
- SawaYMorishitaRSuzukiKA novel strategy for myocardial protection using in vivo transfection of cis element ‘decoy’ against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injuryCirculation1997969 Suppl280284
- DajeeMMuchamuelTSchryverBBlockade of experimental atopic dermatitis via topical NF-kappaB decoy oligonucleotideJ Invest Dermatol200612681792180316628194
- de StefanoDOligonucleotides decoy to NF-kappaB: becoming a reality?Discov Med201112639710521878187
- TaharaKSamuraSTsujiKOral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel diseaseBiomaterials201132387087820934748
- FarahmandLDarvishiBMajidzadeh-AKSuppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotidesDrug Deliv20172411249126128870118
- TamaiKKanedaYMorishitaRKatayamaIDevelopment of NF-kappa B decoy ointment and clinical trial for atopic dermatitisDermatitis200819293294
- DoucasVShiYMiyamotoSWestAVermaIEvansRMCytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptorProc Natl Acad Sci U S A20009722118931189811027313
- RayAPrefontaineKEPhysical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptorProc Natl Acad Sci U S A19949127527568290595
- LesovayaEYemelyanovASwartACSwartPHaegemanGBudunovaIDiscovery of compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activityOncotarget2015631307303074426436695
- SchäckeHBergerMRehwinkelHAsadullahKSelective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic indexMol Cell Endocrinol20072751–210911717630119
- SundahlNBridelanceJLibertCde BosscherKBeckIMSelective glucocorticoid receptor modulation: new directions with non-steroidal scaffoldsPharmacol Ther2015152284125958032
- CarsonMWLuzJGSuenCGlucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based designJ Med Chem201457384986024446728
- StockTFleishakerDWangXMukherjeeAMebusCImproved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized studyInt J Rheum Dis201720896097028328159
- CatleyMDissociated steroidsScientificWorldJournal2007742143017450306
- ParkSYKimMJKimYJSelective PCAF inhibitor ameliorates cognitive and behavioral deficits by suppressing NF-κB-mediated neuroinflammation induced by Aβ in a model of Alzheimer’s diseaseInt J Mol Med20153541109111825672970
- van den BoschTLeusNGJWapenaarHA 6-alkylsalicylate histone acetyltransferase inhibitor inhibits histone acetylation and pro-inflammatory gene expression in murine precision-cut lung slicesPulm Pharmacol Ther201744889528323055
- LegartováSStixováLStrnadHBasic nuclear processes affected by histone acetyltransferases and histone deacetylase inhibitorsEpigenomics20135437939623895652
- XuJSunJWangPMaXLiSPendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugsJ Drug Target2018265–644845729251528
- LiXZhangJXieYJiangYYingjieZXuWProgress of HDAC inhibitor panobinostat in the treatment of cancerCurr Drug Targets201415662263424597570
- GaoSLiXZangJXuWZhangYPreclinical and clinical studies of chidamide (CS055/HBI-8000), an orally available subtype-selective HDAC inhibitor for cancer therapyAnticancer Agents Med Chem201717680281227592546
- LeusNGvan den BoschTvan der WoudenPEHDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in miceSci Rep201774504728344354
- NencioniABeckJWerthDHistone deacetylase inhibitors affect dendritic cell differentiation and immunogenicityClin Cancer Res200713133933394117606727
- ChoiYParkSKKimHMHistone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia modelExp Mol Med200840557458118985016
- LeusNGZwindermanMRDekkerFJHistone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammationCurr Opin Chem Biol20163316016827371876
- WinklerARNockaKNWilliamsCMSmoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine productionPulm Pharmacol Ther201225428629222613758
- LeusNGvan der WoudenPEvan den BoschTHDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activityBiochem Pharmacol2016108587426993378
- ChenDZengSHuangMXuHLiangLYangXRole of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritisJ Cell Mol Med201721478179027860244
- WebbLMAmiciSAJablonskiKAPRMT5-selective inhibitors suppress inflammatory T cell responses and experimental autoimmune encephalomyelitisJ Immunol201719841439145128087667
- SrinivasanMLahiriDKSignificance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer’s disease and multiple sclerosisExpert Opin Ther Targets201519447148725652642
- KanazawaTHamasakiTEndoTFunctional peptide nanocarriers for delivery of novel anti-RelA RNA interference agents as a topical treatment of atopic dermatitisInt J Pharm20154891–226126725956048
- DeciMBLiuMDinhQTNguyenJPrecision engineering of targeted nanocarriersWiley Interdiscip Rev Nanomed Nanobiotechnol Epub2018213